Endoscopic cell sheet transplantation device developed by using a 3-dimensional printer and its feasibility evaluation in a porcine model - 13/06/15
Abstract |
Background |
To prevent severe esophageal stenosis after aggressive endoscopic submucosal dissection (ESD), our group previously reported an efficient treatment using cell sheets that had been fabricated from patient cells. However, this transplantation procedure had not been easy for every endoscopist and needed to be improved to derive the full effect of epithelial cell sheets.
Objective |
To develop an endoscopic device that enables easy and effective cell sheet transplantation and to evaluate its performance and clinical feasibility.
Design |
Animal study.
Setting |
Animal experimentation laboratory.
Intervention |
Three pigs underwent circumferential esophageal ESD while under general anesthesia. A total of 12 cell sheets were endoscopically transplanted to the ESD site; 6 cell sheets were transplanted by using an endoscopic device that we developed, and 6 cell sheets were transplanted by using the conventional method.
Main Outcome Measurements |
Procedure time, transplanted area on the ESD site, transplantation success rate, and monitoring of adverse events or incidents.
Results |
The device allowed successful transplantation of all cell sheets with a shorter procedure time than with the conventional method (4.8 ± 0.8 minutes vs 13.3 ± 5.7 minutes, respectively) (P = .005) and onto a larger area (111.3 ± 56.3 mm2 vs 41.8 ± 4.2 mm2, respectively) (P = .023) with a higher success rate (100% vs 83%, respectively). No adverse incidents were monitored in each method.
Limitations |
Animal study, small sample.
Conclusion |
A newly designed endoscopic cell sheet transplantation device would be useful.
Le texte complet de cet article est disponible en PDF.Abbreviation : ESD
Plan
| DISCLOSURE: Dr Okano is a founder of CellSeed Inc, is a member of the Board of Directors of CellSeed Inc and has licensed technologies and patents from Tokyo Women's Medical University related to this study and is a shareholder in CellSeed Inc. Dr Yamato is a consultant and shareholder in CellSeed Inc. All other authors disclosed no financial relationships relevant to this article. This study was supported by Grant-in-Aid for Scientific Research (14483609 to Dr Kanai), Cell Sheet Tissue Engineering Center (CSTEC), The Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program” from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a Health Labor Scientific Research Grants (26220101 to Dr Okano and 26270801 to Dr Yamato). |
Vol 82 - N° 1
P. 147-152 - juillet 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
